G1 Therapeutics (GTHX) P/E US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -8.12 | -6.87 | -2.89 | 0.00 | 0.00 | -8.39 | ||
| Changes by years, y/y, % | +9% | -15% | -58% | -100% | -100.0% | ||||
G1 Therapeutics. P/E
G1 Therapeutics. P/E, changes, %
G1 Therapeutics (GTHX) P/E US GAAP (quarter values) |
||||||||
| FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | LTM ? | |||
| P/E | ? | -1.55 | 0.00 | 0.00 | 0.00 | 0.00 | -8.39 | |
| Changes by years, y/y, % | +30% | -100% | -100% | -100% | ||||
| Changes by quarters, q/q, % | +50% | -100% | ||||||